Sign in

CIK 0001590750 · Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471187261
Phone
617.272.4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 8-K Event Regulation FD disclosure · Other events
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 4 Insider Changes in Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. 144 Insider Sale of Securities
  8. 4 Insider Changes in Ownership
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 1 of 41 · 819 filings